Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
CDTG - CDT Environmental Technology Investment Holdings Ltd - Stock Price Chart
TickerCDTG [NASD]
CompanyCDT Environmental Technology Investment Holdings Ltd
CountryChina
IndustryWaste Management
Market Cap38.73MEPS (ttm)0.10
P/E37.36EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S8.04EPS next 5Y-
P/B8.61EPS Q/Q5.14%
Dividend-Sales Q/Q13.16%
Insider Own69.22%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.07%Earnings-
Analyst Recom-Target Price-
Avg Volume35.49K52W Range2.76 - 4.60
CDT Environmental Technology Investment Holdings Ltd. is a holding company, which engages in developing, producing, selling and installing sewage treatment systems and providing sewage treatment services. The firm operates through the Sewage Treatment Systems and Sewage Treatment Services and Others business lines. The Sewage Treatment Systems sells and installs proprietary rural sewage treatment systems and provides on-going operation and maintenance services to its customers. The Sewage Treatment Services and Others offers on-site treatment services with its mobile and fixed septic tank treatment systems. The company was founded on November 28, 2016, and is headquartered in Shenzhen, China.
BCTX - BriaCell Therapeutics Corp - Stock Price Chart
TickerBCTX [NASD]
CompanyBriaCell Therapeutics Corp
CountryCanada
IndustryBiotechnology
Market Cap24.50MEPS (ttm)-1.25
P/E-EPS this Y-6.92%
Forward P/E-EPS next Y28.06%
PEG-EPS past 5Y32.71%
P/S-EPS next 5Y-
P/B-EPS Q/Q134.04%
Dividend-Sales Q/Q-
Insider Own15.45%Inst Own12.04%
Insider Trans47.00%Inst Trans-
Short Float4.18%EarningsJun 17/b
Analyst Recom1.00Target Price18.00
Avg Volume121.68K52W Range1.27 - 7.59
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lustig MarcDirectorMay 14 '24Buy2.21902,9352,000,0012,542,935May 20 04:00 PM
AKA - a.k.a. Brands Holding Corp - Stock Price Chart
TickerAKA [NYSE]
Companya.k.a. Brands Holding Corp
CountryUSA
IndustryInternet Retail
Market Cap150.70MEPS (ttm)-9.21
P/E-EPS this Y82.28%
Forward P/E-EPS next Y29.16%
PEG-EPS past 5Y-
P/S0.28EPS next 5Y-
P/B1.11EPS Q/Q4.42%
Dividend-Sales Q/Q-3.03%
Insider Own94.39%Inst Own0.38%
Insider Trans0.00%Inst Trans28.51%
Short Float10.92%EarningsMay 08/a
Analyst Recom2.60Target Price22.50
Avg Volume8.75K52W Range3.81 - 33.73
a.k.a. Brands Holding Corp. engages in the provision of a portfolio of online fashion products through its digital platform. It operates through the Online and Stores business segments. The Online segment offers fashion products through Culture Kings. The Stores segment provides retail services. The company was founded on May 19, 2021 and is headquartered in San Francisco, CA.
ZURA - Zura Bio Ltd - Stock Price Chart
TickerZURA [NASD, RUT]
CompanyZura Bio Ltd
CountryUSA
IndustryBiotechnology
Market Cap215.24MEPS (ttm)-1.64
P/E-EPS this Y75.02%
Forward P/E-EPS next Y-54.12%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.42EPS Q/Q99.43%
Dividend-Sales Q/Q-
Insider Own48.08%Inst Own37.36%
Insider Trans4.93%Inst Trans1.77%
Short Float1.72%EarningsMay 09/b
Analyst Recom1.00Target Price17.80
Avg Volume328.46K52W Range2.00 - 13.00
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ploos van Amstel ArnoutDirectorMay 17 '24Buy6.2080,000496,000100,000May 23 08:53 AM
Sidhu SomeitDirectorApr 22 '24Buy3.131,186,9013,715,0001,186,901Apr 24 06:51 PM
Munshi AmitDirectorApr 22 '24Buy3.13159,744499,999777,384Apr 24 06:52 PM
Howell MichaelSee RemarksApr 22 '24Buy3.137,98724,9997,987Apr 24 06:54 PM
Nistala KiranExecutive Vice PresidentApr 22 '24Buy3.133,19510,0003,195Apr 24 06:53 PM
AXDX - Accelerate Diagnostics Inc - Stock Price Chart
TickerAXDX [NASD]
CompanyAccelerate Diagnostics Inc
CountryUSA
IndustryMedical Devices
Market Cap25.58MEPS (ttm)-4.54
P/E-EPS this Y62.83%
Forward P/E-EPS next Y25.69%
PEG-EPS past 5Y21.16%
P/S2.10EPS next 5Y30.00%
P/B-EPS Q/Q56.66%
Dividend-Sales Q/Q3.88%
Insider Own44.58%Inst Own20.95%
Insider Trans-0.99%Inst Trans-
Short Float3.47%EarningsMay 08/a
Analyst Recom2.00Target Price1.00
Avg Volume77.80K52W Range0.73 - 8.72
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BURRIS WAYNEDirectorMay 31 '24Option Exercise0.0083901,678Jun 03 05:06 PM
MASSARANY HANYDirectorMay 29 '24Option Exercise0.007,894032,154May 30 04:16 PM
FRANCESCONI LOUISEDirectorMay 29 '24Option Exercise0.007,894028,821May 30 04:25 PM
Regan JenniferDirectorMay 29 '24Option Exercise0.0012,631012,631May 30 04:25 PM
SCHULER JACK WDirectorMay 29 '24Option Exercise0.007,894015,488May 30 04:25 PM
SER - Serina Therapeutics Inc. - Stock Price Chart
TickerSER [AMEX]
CompanySerina Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap97.56MEPS (ttm)-13.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-12.67%
P/S696.83EPS next 5Y-
P/B2.29EPS Q/Q-27.85%
Dividend-Sales Q/Q600.00%
Insider Own25.96%Inst Own1.37%
Insider Trans1.52%Inst Trans-3.08%
Short Float0.15%Earnings-
Analyst Recom-Target Price-
Avg Volume12.47K52W Range7.86 - 35.17
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailey GregoryDirectorMay 30 '24Buy9.505,20549,44820,206May 31 04:18 PM
Bailey GregoryDirectorMay 29 '24Buy9.501,17311,14415,001May 31 04:18 PM
Bailey GregoryDirectorMay 28 '24Buy9.509,01985,68013,828May 29 04:15 PM
Bailey GregoryDirectorMay 23 '24Buy9.502,37122,5244,809May 24 04:15 PM
MINTZ STEVENDirectorMay 21 '24Buy9.939,15190,8859,900May 23 05:07 PM
BENF - Beneficient - Stock Price Chart
TickerBENF [NASD]
CompanyBeneficient
CountryUSA
IndustryAsset Management
Market Cap11.26MEPS (ttm)-279.47
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S19.09EPS next 5Y-
P/B-EPS Q/Q-363081.65%
Dividend-Sales Q/Q-
Insider Own63.63%Inst Own15.86%
Insider Trans17.90%Inst Trans98.10%
Short Float1.75%EarningsFeb 13/a
Analyst Recom-Target Price-
Avg Volume857.42K52W Range1.86 - 401.60
Beneficient provides alternative asset, financial and investment services. It offers services to individual investors, wealth advisors, general partners, and institutional investors. The company was founded on June 6, 2023 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CANGANY PETER T JRDirectorFeb 21 '24Buy0.25200,00050,000200,000Feb 22 04:46 PM
CANGANY PETER T JRDirectorFeb 20 '24Buy0.26200,00052,000200,000Feb 22 04:46 PM
CTCX - Carmell Corp - Stock Price Chart
TickerCTCX [NASD]
CompanyCarmell Corp
CountryUSA
IndustryHousehold & Personal Products
Market Cap34.15MEPS (ttm)-0.56
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S9.15EPS next 5Y-
P/B-EPS Q/Q-1833.06%
Dividend-Sales Q/Q-
Insider Own33.92%Inst Own16.14%
Insider Trans0.39%Inst Trans4.76%
Short Float0.26%Earnings-
Analyst Recom-Target Price-
Avg Volume11.46K52W Range1.70 - 13.31
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Upton Richard ADirectorJun 12 '24Buy2.202,0004,4096,400Jun 14 08:21 AM
Cassaday Bryan J.Chief Financial OfficerJun 10 '24Buy2.504401,1002,775Jun 12 07:59 AM
Shukla RajivChairman and CEOJun 06 '24Buy2.632,1005,52772,103Jun 10 09:03 AM
Shukla RajivChairman and CEOMay 30 '24Buy2.502,0005,00070,003Jun 10 09:03 AM
Cassaday Bryan J.Chief Financial OfficerMay 30 '24Buy2.553659312,335May 31 05:25 PM
AGEN - Agenus Inc - Stock Price Chart
TickerAGEN [NASD, RUT]
CompanyAgenus Inc
CountryUSA
IndustryBiotechnology
Market Cap272.79MEPS (ttm)-12.62
P/E-EPS this Y35.33%
Forward P/E-EPS next Y2.78%
PEG-EPS past 5Y13.79%
P/S1.69EPS next 5Y-
P/B-EPS Q/Q29.41%
Dividend-Sales Q/Q22.28%
Insider Own4.95%Inst Own51.90%
Insider Trans92.68%Inst Trans-
Short Float13.69%EarningsMay 07/b
Analyst Recom1.20Target Price44.25
Avg Volume789.53K52W Range4.78 - 38.60
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMEN GARO HSee RemarksFeb 15 '24Buy0.65500,000324,050625,969Feb 15 06:59 PM
WIINBERG ULFDirectorNov 15 '23Buy0.7625,00019,000124,063Nov 17 04:22 PM
AGENUS INC10% OwnerOct 16 '23Buy1.1042947221,772,863Oct 16 05:49 PM
AGENUS INC10% OwnerOct 13 '23Buy1.1019,37321,31021,772,434Oct 16 05:49 PM
AGENUS INC10% OwnerOct 12 '23Buy1.103,1733,48821,753,061Oct 16 05:49 PM
CHPT - ChargePoint Holdings Inc - Stock Price Chart
TickerCHPT [NYSE]
CompanyChargePoint Holdings Inc
CountryUSA
IndustrySpecialty Retail
Market Cap637.95MEPS (ttm)-1.17
P/E-EPS this Y53.66%
Forward P/E-EPS next Y41.17%
PEG-EPS past 5Y-149.12%
P/S1.32EPS next 5Y-
P/B2.29EPS Q/Q25.22%
Dividend-Sales Q/Q-17.68%
Insider Own8.07%Inst Own37.70%
Insider Trans-4.79%Inst Trans-0.39%
Short Float28.83%EarningsJun 05/a
Analyst Recom2.55Target Price2.83
Avg Volume12.52M52W Range1.21 - 9.23
ChargePoint Holdings, Inc. operates as an electric vehicle charging network provider. It designs, develops and markets networked electric vehicle charging system infrastructure and its Cloud Services enable consumers the ability to locate, reserve, authenticate and transact electric vehicle charging sessions. The firm provides an open platform providing real-time information about charging sessions and control, support and management of the networked charging systems. This network provides multiple web-based portals for charging system owners, fleet managers, drivers and utilities. The company was founded in 2007 and is headquartered in Campbell, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilmer RichardPresident and CEOMar 21 '24Sale1.8725,37647,4532,359,462Mar 21 09:50 PM
Khetani MansiInterim CFOMar 21 '24Sale1.8719,03535,595421,500Mar 21 09:50 PM
Singh Jagdeep CACCXOMar 21 '24Sale1.879,48517,737484,503Mar 21 09:50 PM
Gerdes HenrikChief Accounting OfficerMar 21 '24Sale1.875,60710,485220,115Mar 21 09:50 PM
Chavez RebeccaCLO and Corp SecretaryMar 21 '24Sale1.874,8289,028642,690Mar 21 09:51 PM
15678910111213141520